BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33270085)

  • 21. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer.
    Wu J; Wang Y; Jiang Z
    J Gastrointest Cancer; 2021 Mar; 52(1):150-159. PubMed ID: 32077004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatic Analysis of Prognostic and Immune-Related Genes in Pancreatic Cancer.
    Li Z; Hu C; Yang Z; Yang M; Fang J; Zhou X
    Comput Math Methods Med; 2021; 2021():5549298. PubMed ID: 34394706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
    Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
    Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphoprotein phosphatase 1 complexes in spermatogenesis.
    Silva JV; Freitas MJ; Fardilha M
    Curr Mol Pharmacol; 2014; 7(2):136-46. PubMed ID: 25620225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse.
    Gu P; Qi X; Zhou Y; Wang Y; Gao X
    Genesis; 2012 May; 50(5):429-36. PubMed ID: 21998041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
    Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
    Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
    [No Abstract]   [Full Text] [Related]  

  • 28. PPP3CB Inhibits Migration of G401 Cells via Regulating Epithelial-to-Mesenchymal Transition and Promotes G401 Cells Growth.
    Chen L; He Q; Liu Y; Wu Y; Ni D; Liu J; Hu Y; Gu Y; Xie Y; Zhou Q; Li Q
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PHLPP2 is a novel biomarker and epigenetic target for the treatment of vitamin C in pancreatic cancer.
    Chen L; Song H; Luo Z; Cui H; Zheng W; Liu Y; Li W; Luo F; Liu J
    Int J Oncol; 2020 May; 56(5):1294-1303. PubMed ID: 32319585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a differentially expressed gene PPP1CB between porcine Longissimus dorsi of Meishan and Large WhitexMeishan hybrids.
    Huang T; Xiong YZ; Lei MG; Xu DQ; Deng CY
    Acta Biochim Biophys Sin (Shanghai); 2006 Jul; 38(7):450-6. PubMed ID: 16820860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Widespread presence of "bacterial-like" PPP phosphatases in eukaryotes.
    Andreeva AV; Kutuzov MA
    BMC Evol Biol; 2004 Nov; 4():47. PubMed ID: 15555063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer.
    Zhu B; Huo R; Zhi Q; Zhan M; Chen X; Hua ZC
    J Trace Elem Med Biol; 2021 May; 65():126734. PubMed ID: 33631610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmodium falciparum serine/threonine phoshoprotein phosphatases (PPP): from housekeeper to the 'holy grail'.
    Bajsa J; Duke SO; Tekwani BL
    Curr Drug Targets; 2008 Nov; 9(11):997-1012. PubMed ID: 18991611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxytocin and oxytocin receptor alterations, decreased survival, and increased chemoresistance in patients with pancreatic cancer.
    Harricharran T; Ogunwobi OO
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):175-180. PubMed ID: 31919036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.
    Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
    Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.
    Prowatke I; Devens F; Benner A; Gröne EF; Mertens D; Gröne HJ; Lichter P; Joos S
    Br J Cancer; 2007 Jan; 96(1):82-8. PubMed ID: 17146477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
    Li Y; Liu Z; Zhang Y
    BMC Gastroenterol; 2021 Feb; 21(1):79. PubMed ID: 33618667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray.
    Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW
    Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arabidopsis PPP family of serine/threonine protein phosphatases: many targets but few engines.
    Uhrig RG; Labandera AM; Moorhead GB
    Trends Plant Sci; 2013 Sep; 18(9):505-13. PubMed ID: 23790269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.